Financial Counselors Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-3,298
Closed -$306K – 601
2024
Q2
$306K Buy
3,298
+250
+8% +$22.4K ﹤0.01% 485
2024
Q1
$289K Buy
+3,048
New +$283K ﹤0.01% 505
2021
Q4
– Sell
-15,161
Closed -$1.91M – 543
2021
Q3
$1.91M Buy
15,161
+479
+3% +$61.7K 0.04% 266
2021
Q2
$1.99M Sell
14,682
-1,419
-9% -$187K 0.04% 255
2021
Q1
$2.18M Buy
16,101
+91
+0.6% +$13.6K 0.05% 246
2020
Q4
$2.25M Sell
16,010
-1,077
-6% -$138K 0.06% 243
2020
Q3
$1.9M Sell
17,087
-24
-0.1% -$2.69K 0.06% 241
2020
Q2
$1.92M Buy
+17,111
New +$1.69M 0.06% 245

Other funds holding XBI

Financial Counselors Inc's XBI Position: Q3 2024 in Review

Financial Counselors Inc sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 3,298 shares — an estimated $306K sold.

Financial Counselors Inc first reported a position in XBI in Q2 2020 and held it in 8 quarters. The position peaked at $2.25M in Q4 2020. 770 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Financial Counselors Inc reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
  • Financial Counselors Inc sold 3,298 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $306K.
  • Financial Counselors Inc first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 8 quarters.
  • Financial Counselors Inc's State Street SPDR S&P Biotech ETF position peaked at $2.25M in Q4 2020.
  • 770 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Financial Counselors Inc's 13F filing for Q3 2024, filed 14 Nov 2024.